Recherche - Traitement Spastic paraplegia Funding - Research - Treatment
Private foundation · Ottawa, Ontario · BN 800238727RR0001 · Foundations
Source: T3010 return, FPE 2024-08-31. Split of total expenditures ($5,437) as filed with the CRA.
Recherche - Traitement Spastic paraplegia Funding - Research - Treatment is a private foundation based in Ottawa, Ontario, classified by the CRA under foundations. In its fiscal year ending August 31, 2024, it reported $5,437 in revenue and $5,437 in expenditures.
Its funding that year was roughly 100% from donations. In 2024, 1 other registered charity reported granting it a combined $52.
Compared with 3,025 grantmaking charities of similar size, its share of spending on mission — charitable programs plus grants to other charities — ranked above 80% of peers.
Revenue has grown substantially over its filings on record here, from $1,127 in 2020 to $5,437 in 2024. Its filed list of directors and trustees shows 2 names.
In its own words
The basic objective of funding medical research into hereditary spastic paraplegia (HSP) through fundraising efforts still holds true. Although the efforts of the foundation were very limited again this year they did exist - mostly based on electronic means. This year a research collaboration was established with a Canadian university and a cohort of HSP subjects was established to advance medical research into this rare movement disorder.
Ongoing-program description from its T3010 filing, verbatim.
The ledger, 2020–2024
| Year | Revenue | Spending | Programs | Fundraising | Gifts out | Net assets |
|---|---|---|---|---|---|---|
| 2024 | $5,437 | $5,437 | $0 | — | $5,437 | $844 |
| 2023 | $6,107 | $8,900 | $0 | — | $8,900 | $0 |
| 2022 | $1,252 | $1,065 | $0 | $0 | $0 | $6,788 |
| 2021 | $729 | $470 | — | — | — | -$7,701 |
| 2020 | $1,127 | $693 | — | — | — | -$7,960 |
Revenue printed in red where the year ran a deficit. Fiscal years by period end.
Money between charities, 2024
Received $52 from 1 charity:
As reported on the donors’ own T3010 qualified-donee schedules.
Directors & trustees (2024)
Julie Desmarais-Trépanier (original founder); Linda Lafontaine (president).
As listed on its 2024 return.
Check the source
Every figure on this page is from Recherche - Traitement Spastic paraplegia Funding - Research - Treatment’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 800238727RR0001), or read how we compute the receipt.